| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 323791 | Hormones and Behavior | 2008 | 10 Pages |
Abstract
Reduced androgen levels in aged men and women might be risk factors for age-related cognitive decline and Alzheimer's disease (AD). Ongoing clinical trials are designed to evaluate the potential benefit of estrogen in women and of testosterone in men. In this review, we discuss the potential beneficial effects of androgens and androgen receptors (ARs) in males and females. In addition, we discuss the hypothesis that AR interacts with apolipoprotein (apoE)4, encoded by ε4 and a risk factor for age-related cognitive decline and AD, and the potential consequences of this interaction.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Jacob Raber,